'In this study, we report that high CDK6 expression positively correlates with immunotherapy resistance in 6 of 7 single-agent immunotherapy clinical studies for melanoma patients. CDK6 depletion, but not that of CDK4, cyclin D1, or D2, in cells of the TME inhibits tumor growth.'
#immunotherapy #immunology

https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00325-X